Cargando…

Clinical outcomes of a new diffractive trifocal intraocular lens with Enhanced Depth of Focus (EDOF)

BACKGROUND: To evaluate the clinical outcomes after the implantation of a new trifocal diffractive intraocular lens (IOL) combined with Enhanced depth of focus (EDOF) technology. METHODS: The study enrolled 80 eyes of 40 patients who underwent cataract surgery with bilateral implantation of a diffra...

Descripción completa

Detalles Bibliográficos
Autores principales: Torun Acar, Banu, Duman, Erkan, Simsek, Saban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129192/
https://www.ncbi.nlm.nih.gov/pubmed/27899084
http://dx.doi.org/10.1186/s12886-016-0389-8
_version_ 1782470543550709760
author Torun Acar, Banu
Duman, Erkan
Simsek, Saban
author_facet Torun Acar, Banu
Duman, Erkan
Simsek, Saban
author_sort Torun Acar, Banu
collection PubMed
description BACKGROUND: To evaluate the clinical outcomes after the implantation of a new trifocal diffractive intraocular lens (IOL) combined with Enhanced depth of focus (EDOF) technology. METHODS: The study enrolled 80 eyes of 40 patients who underwent cataract surgery with bilateral implantation of a diffractive trifocal IOL (Reviol Tri-ED) designed with a combination of enhanced depth of focus. Mean age was 52.09 ± 11.32 years (range from 45 to 70 years). Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected intermediate visual acuity (UIVA), corrected intermediate visual acuity (CIVA), uncorrected near visual acuity (UNVA), corrected near visual acuity (CNVA), keratometry (K), and manifest refraction spherical equivalent (MRSE) were evaluated pre- and postoperatively. The contrast sensitivity, defocus curves, and a questionnaire evaluating individual satisfaction were also estimated. RESULTS: There was a significant improvement in UDVA, CDVA, UNVA, CNVA, CIVA postoperatively. The defocus curve confirmed good visual acuity also in the intermediate distance. The postoperative MRSE was ranged from −0.75 to 0.75 diopters. Contrast sensitivity also significantly improved postoperatively. The patient satisfaction was high. CONCLUSION: The new trifocal EDOF IOL provides visual improvement for far, intermediate, and near distances with a high level of visual quality and patient satisfaction.
format Online
Article
Text
id pubmed-5129192
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51291922016-12-12 Clinical outcomes of a new diffractive trifocal intraocular lens with Enhanced Depth of Focus (EDOF) Torun Acar, Banu Duman, Erkan Simsek, Saban BMC Ophthalmol Research Article BACKGROUND: To evaluate the clinical outcomes after the implantation of a new trifocal diffractive intraocular lens (IOL) combined with Enhanced depth of focus (EDOF) technology. METHODS: The study enrolled 80 eyes of 40 patients who underwent cataract surgery with bilateral implantation of a diffractive trifocal IOL (Reviol Tri-ED) designed with a combination of enhanced depth of focus. Mean age was 52.09 ± 11.32 years (range from 45 to 70 years). Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected intermediate visual acuity (UIVA), corrected intermediate visual acuity (CIVA), uncorrected near visual acuity (UNVA), corrected near visual acuity (CNVA), keratometry (K), and manifest refraction spherical equivalent (MRSE) were evaluated pre- and postoperatively. The contrast sensitivity, defocus curves, and a questionnaire evaluating individual satisfaction were also estimated. RESULTS: There was a significant improvement in UDVA, CDVA, UNVA, CNVA, CIVA postoperatively. The defocus curve confirmed good visual acuity also in the intermediate distance. The postoperative MRSE was ranged from −0.75 to 0.75 diopters. Contrast sensitivity also significantly improved postoperatively. The patient satisfaction was high. CONCLUSION: The new trifocal EDOF IOL provides visual improvement for far, intermediate, and near distances with a high level of visual quality and patient satisfaction. BioMed Central 2016-11-29 /pmc/articles/PMC5129192/ /pubmed/27899084 http://dx.doi.org/10.1186/s12886-016-0389-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Torun Acar, Banu
Duman, Erkan
Simsek, Saban
Clinical outcomes of a new diffractive trifocal intraocular lens with Enhanced Depth of Focus (EDOF)
title Clinical outcomes of a new diffractive trifocal intraocular lens with Enhanced Depth of Focus (EDOF)
title_full Clinical outcomes of a new diffractive trifocal intraocular lens with Enhanced Depth of Focus (EDOF)
title_fullStr Clinical outcomes of a new diffractive trifocal intraocular lens with Enhanced Depth of Focus (EDOF)
title_full_unstemmed Clinical outcomes of a new diffractive trifocal intraocular lens with Enhanced Depth of Focus (EDOF)
title_short Clinical outcomes of a new diffractive trifocal intraocular lens with Enhanced Depth of Focus (EDOF)
title_sort clinical outcomes of a new diffractive trifocal intraocular lens with enhanced depth of focus (edof)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129192/
https://www.ncbi.nlm.nih.gov/pubmed/27899084
http://dx.doi.org/10.1186/s12886-016-0389-8
work_keys_str_mv AT torunacarbanu clinicaloutcomesofanewdiffractivetrifocalintraocularlenswithenhanceddepthoffocusedof
AT dumanerkan clinicaloutcomesofanewdiffractivetrifocalintraocularlenswithenhanceddepthoffocusedof
AT simseksaban clinicaloutcomesofanewdiffractivetrifocalintraocularlenswithenhanceddepthoffocusedof